Key moments
The drug removes beta-amyloid, one of the hallmarks of Alzheimer's disease, from the brain...
The drug removes beta-amyloid, one of the hallmarks of Alzheimer's disease, from the brain...
0:16
Which in turn, reduces cognitive and functional decline in people living with early Alzheimer's
Which in turn, reduces cognitive and functional decline in people living with early Alzheimer's
0:25
Which in turn, reduces cognitive and functional decline in people living with early Alzheimer's
0:25
Last month, the European Medicines Agency (EMA) rejected the marketing authorization for Aduhelm...
Last month, the European Medicines Agency (EMA) rejected the marketing authorization for Aduhelm...
0:52
Last month, the European Medicines Agency (EMA) rejected the marketing authorization for Aduhelm...
0:52
Sync to video time
Description
20Likes
2,081Views
2022Jan 3
Key moments
View all
View all
The drug removes beta-amyloid, one of the hallmarks of Alzheimer's disease, from the brain...
The drug removes beta-amyloid, one of the hallmarks of Alzheimer's disease, from the brain...
0:16
Which in turn, reduces cognitive and functional decline in people living with early Alzheimer's
Which in turn, reduces cognitive and functional decline in people living with early Alzheimer's
0:25
Last month, the European Medicines Agency (EMA) rejected the marketing authorization for Aduhelm...
Last month, the European Medicines Agency (EMA) rejected the marketing authorization for Aduhelm...
0:52
World Israel News
2.88K subscribers
NaN / NaN